You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
HPS-162 - Risk of ocular adverse events with Trastuzumab: A case report
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: HPS-162
- By: HUANG, Tzu Yu (Min-Sheng General Hospital, China Taiwan)
- Co-author(s): Pharmacist Tzu Yu Huang
- Abstract:
Background
Trastuzumab is a monoclonal antibody targeting the HER-2/neu antigen. It inhibits cancer cells that overexpress HER-2/neu. Approximately 25–30% of breast cancer patients exhibit HER-2 overexpression. Studies indicate that these patients generally have a poorer prognosis compared to those without HER-2 overexpression. Common adverse.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026